Egetis Therapeutics AB (SE0003815604) — research page
SE · se-cm-kg/XSTO/SE0003815604 · as of 2026-11-06
Identity and listing
The issuer is Egetis Therapeutics AB, listed on Nasdaq Stockholm under the ticker SE0003815604, with ISIN SE0003815604 and LEI 549300RZCKGWRUBPMY22. Security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Egetis Therapeutics AB | source · 2026-11-06 |
| exchange | Nasdaq Stockholm | source · 2026-11-06 |
| ticker | SE0003815604 | source · 2026-11-06 |
| ISIN | SE0003815604 | source · 2026-11-06 |
| LEI | 549300RZCKGWRUBPMY22 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 52 filings across 49 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 6.0 days, and the median for Nasdaq Stockholm across 398 issuers is 9.5 days. The latency from the latest filing to the record date is 1 day, and the Nasdaq Stockholm median is 7.0 days. The sector median is not on the record. The latest filing is an Interim report (Q1 and Q3), dated 2026-11-05.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 52 | 6 | 1 |
| exchange median: Nasdaq Stockholm (398 issuers) | 30 | 9.5 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | Interim report (Q1 and Q3) | Interim report (Q1 and Q3) | Interim report Q3 2026 |
| 2026-11-05 | Inside information | Inside information | Statement by the Board of Directors of Egetis Therapeutics in relation to the public cash offer from ANI Pharmaceuticals |
| 2026-11-04 | Inside information | Inside information | Egetis Therapeutics Enters Agreement to Sell Priority Review Voucher for USD 190 Million |
| 2026-10-27 | Investor News | Investor News | Egetis Therapeutics Announces U.S. Launch of EMCITATE® for Patients with MCT8 Deficiency |
| 2026-10-21 | Investor News | Investor News | Egetis' Nomination Committee for the 2027 Annual General Meeting |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is not on the record, and neither is its location. Auditor changes are not on the record, because this register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, because this register has no lifecycle type map yet. The halt flag is listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 5 research houses: Cantor, DNB Carnegie, Pareto Securities, Stifel and Van Lanschot Kempen.
| research house | analyst | source · read date |
|---|---|---|
| Cantor | Kristen Kluska & Ayan Hussein | issuer page · 2026-11-12 |
| DNB Carnegie | Arvid Necander & Erik Hultgård | issuer page · 2026-11-12 |
| Pareto Securities | Chien-Hsun Lee | issuer page · 2026-11-12 |
| Stifel | Clemence Thiers & Damien Choplain | issuer page · 2026-11-12 |
| Van Lanschot Kempen | Chiara Montironi | issuer page · 2026-11-12 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage of this market is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record.
Sources
7 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/XSTO/SE0003815604 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://www.egetis.com/investors/analysts/ (coverage)
- 10.7
- https://mcp.se-cm-kg.ai/record/XSTO/SE0003815604 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0003815604"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:560288e54938a2d4.